Back to trial details

Intake questionnaire

Immunotherapy Biomarkers to Predict First-line PD(L)1-based Immunotherapy Response and Selection of Second-line Treatment in Stage IIIB-IV Non-small Cell Lung Cancer, IMMUNO-BIOMAP Trial

Applying to City of Hope at Chicago · Zion, Illinois

Answer a few short questions to share with the research team.

0 of 4 answered

1. Are you 18 years old or older?
2. Have you been diagnosed with Lung Non-Small Cell Carcinoma?
3. Are you currently pregnant or breastfeeding?
4. Are you able to travel to Zion for study visits?